NIKKEI 225
38,460.08 +907.92 (+2.42%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.81 0.00 (0.00%) GOLD FUTURES
2,329.40 -9.00 (-0.38%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,598.98 -1,708.38 (-3.20%)
COMPASS Pathways plc (CMPS)
After hours:
| Previous close | 8.25 |
| Open | 8.30 |
| Bid | 8.05 x 500 |
| Ask | 8.13 x 200 |
| Day's range | 7.89 - 8.38 |
| 52-week range | 5.01 - 12.75 |
| Volume | |
| Avg. volume | 712,306 |
| Market cap | 553.574M |
| Beta (5Y monthly) | 2.48 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.32 |
| Earnings date | 06 May 2024 - 10 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 41.25 |
Globe NewswireCompass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference
LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the 23rd Annual Needham Virtual Healthcare Conference at 8:00am ET on April 9, 2024. A live audio webcast of the presentation will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible
Insider Monkey20 Most Depressed Countries in Asia
In this article, we will be taking a look at the 20 most depressed countries in Asia. If you do not want to learn about the Asian depression market, head straight to the 5 Most Depressed Countries in Asia. Overview of the Global and Asian Depression Market The global depression market is a significant sector […]
GlobeNewswireCompass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors
David Norton Assumes Role of Interim Board Chair while the Company Runs a Global Search for a New ChairLONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that Board Chair and co-founder George Goldsmith and fellow co-founder Ekaterina Malievskaia have resigned their seats on the company’s board of directors, effective March 29, 2
